mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.003 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
palmostatin B |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.003 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.005 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
HG-5-88-01 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.006 |